444

JIA JIE BIOMEDICAL CO LTD

No trades
See on Supercharts
Market capitalization
‪2.48 B‬TWD
‪144.15 M‬TWD
‪332.76 M‬TWD
‪93.55 M‬
Beta (1Y)
0.40

About JIA JIE BIOMEDICAL CO LTD

CEO
Ming Chuan Tseng
Headquarters
Kaohsiung City
Founded
1995
ISIN
TW0004109004
FIGI
BBG000BGG7L5
Jia Jie Biomedical Co., Ltd. engages in the processing, selling, and trading of softshell turtle food. It operates through the Taiwan Operating and Mainland China Operating Segments. The Taiwan Operating segment includes production and sale of health food and insurance brokerage. The Mainland China Operating segment refers to the sale of water purification equipment and related parts. The company was founded on May 6, 1995 and is headquartered in Kaohsiung City, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4109 is 24.80 TWD — it has decreased by 1.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange JIA JIE BIOMEDICAL CO LTD stocks are traded under the ticker 4109.
4109 stock is 1.81% volatile and has beta coefficient of 0.40. Check out the list of the most volatile stocks — is JIA JIE BIOMEDICAL CO LTD there?
Yes, you can track JIA JIE BIOMEDICAL CO LTD financials in yearly and quarterly reports right on TradingView.
4109 stock has risen by 0.61% compared to the previous week, the month change is a 7.46% fall, over the last year JIA JIE BIOMEDICAL CO LTD has showed a 47.18% increase.
4109 net income for the last quarter is ‪160.73 M‬ TWD, while the quarter before that showed ‪19.03 M‬ TWD of net income which accounts for 744.66% change. Track more JIA JIE BIOMEDICAL CO LTD financial stats to get the full picture.
Today JIA JIE BIOMEDICAL CO LTD has the market capitalization of ‪2.48 B‬, it has increased by 0.84% over the last week.
Like other stocks, 4109 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIA JIE BIOMEDICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
4109 reached its all-time high on Jul 10, 2014 with the price of 31.50 TWD, and its all-time low was 8.60 TWD and was reached on Sep 14, 2006.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIA JIE BIOMEDICAL CO LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIA JIE BIOMEDICAL CO LTD stock shows the buy signal. See more of JIA JIE BIOMEDICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JIA JIE BIOMEDICAL CO LTD EBITDA is ‪−51.50 M‬ TWD, and current EBITDA margin is −15.48%. See more stats in JIA JIE BIOMEDICAL CO LTD financial statements.